期刊文献+

抗凋亡信号通路在中耳胆脂瘤发病中的作用及药物靶向治疗展望 被引量:2

下载PDF
导出
摘要 自从德国生理学家Mtiller于1838年首次提出“胆脂瘤”概念以来,人们对胆脂瘤的发病机制进行了大量的研究,主要集中在上皮细胞过度增殖、骨质破坏吸收和胆脂瘤上皮细胞凋亡三个方面,但其发病机制至今尚未明确。
出处 《中华耳科学杂志》 CSCD 北大核心 2013年第2期317-321,共5页 Chinese Journal of Otology
基金 2010年湖南省博士研究生科研创新基金资助(编号:CX2010B055)
  • 相关文献

参考文献41

  • 1Olszewska E, Wagner M, Bernal-Sprekelsen M, et al. Etiopathogenesis of cholesteatoma . Eur Arch Otorhinolaryngol, 2004, 261(1): 6-24.
  • 2Sheikholeslani-Zadeh R. Decaestecker C,Delbrouck C, et al. The levels of expression of galectin-3. but not of galeetin-1 and galectin-8, correlate with apoptosis in human cholesteatomas.Laryngo- scope, 2001, 111(6):1042-1047.
  • 3Miyao M, Shinoda H, Takahashi S. Caspase-3, Caspase-8, and nuclear tactor- kappaB expression in human cholesteatoma. Otol Neurotol, 2006, 27(1):8-13.
  • 4Olszewska E , Chodynicki S, Chyczewski L. Apoptosis in the pathogenesis of cholesteatoma in adults . Eur Arch Otorhinolaryngol, 2006, 263(5):409-413.
  • 5Huisman MA, De Heer E, Grote JJ. Cholesteatoma epithelium is charae-terized by increased expression of Ki-67. p53 and p21, with minimal apoptosis. Acta Otolaryngol, 2003, 123(3):377-382.
  • 6Satoh K, Kaneko K, Hirota M, et al. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors .Cancer, 2001, 92(2): 271-278.
  • 7Park HR, Min SK. Min K, et al. Increased expression of p63 and survivin in cholesteatomas. Acta Otolaryngol, 2009. 129(3):268-272.
  • 8Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis. 2004.9(6):667-676.
  • 9Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase Akt pathway in human cancer. Nat Res Cancer, 2002.2(7):489-501.
  • 10Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling path- way and cell survival. J Cell Mol Med, 2005, 9(1):59-71.

二级参考文献20

  • 1Huang P et al. Cell Biol,2001,11(8):343.
  • 2Barragen M et al. Blood,2002, 99(8) : 2969.
  • 3Ringshausen I et al. Blood,2002:100(10):3741.
  • 4Chen EY et al. Cancer Res,2001,61(6):2429.
  • 5Plas DR et al. J Biol Chem,2001,276 : 12041.
  • 6Heiden V et al. Mol Cell Biol,2001,21:5899.
  • 7Henshall DC et al. J Neurosci, 2002, 22(19): 8458.
  • 8Bartling B et al. Biochem Biophys Res Commun ,2000;278:740.
  • 9Gibson EM et al. Cancer Res, 2002, 62 (2): 488.
  • 10Fukuda S et al. Blood. 2002, 100(7): 2463.

共引文献4

同被引文献23

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部